Find Clinical Trials
Evaluation of the effect of the oral administration of perindopril orodispersible at a dose of 0.150 mg/kg/day on the muscular and myocardial function in early stage Duchenne muscular dystrophy. Double blind two years study, randomised versus placebo
Servier Protocol Code:
CL3-90652-004
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2008-003856-32
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Muscular disease
- PERINDOPRIL ARGININE
- S090652
Other study id numbers
Other identification numbers the study may be known by.
- CL3-90652-004